News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
152,605 Results
Type
Article (6773)
Company Profile (8)
Press Release (145823)
Multimedia
Podcasts (8)
Webinars (3)
Section
Business (41961)
Career Advice (263)
Deals (7230)
Drug Delivery (31)
Drug Development (15977)
Employer Resources (13)
FDA (4911)
Job Trends (2884)
News (69914)
Policy (5675)
Tag
Academia (577)
Accelerated approval (12)
Adcomms (2)
Allergies (51)
Alliances (8645)
ALS (40)
Alzheimer's disease (413)
Antibody-drug conjugate (ADC) (113)
Approvals (5095)
Artificial intelligence (99)
Autoimmune disease (52)
Automation (9)
Bankruptcy (58)
Best Places to Work (2525)
BIOSECURE Act (2)
Biosimilars (73)
Biotechnology (8)
Bladder cancer (76)
Brain cancer (24)
Breast cancer (166)
Cancer (1401)
Cardiovascular disease (112)
Career advice (223)
Career pathing (3)
CAR-T (51)
CDC (9)
Cell therapy (193)
Cervical cancer (12)
Clinical research (14023)
Collaboration (346)
Company closure (1)
Compensation (92)
Complete response letters (16)
COVID-19 (592)
CRISPR (22)
C-suite (166)
Cystic fibrosis (24)
Data (2038)
Denatured (1)
Depression (32)
Dermatology (20)
Diabetes (128)
Diagnostics (1506)
Digital health (18)
Diversity (2)
Diversity, equity & inclusion (3)
Drug discovery (64)
Drug pricing (44)
Drug shortages (4)
Duchenne muscular dystrophy (43)
Earnings (26283)
Editorial (12)
Employer branding (3)
Employer resources (14)
Events (24620)
Executive appointments (141)
FDA (6029)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (7)
Frontotemporal dementia (3)
Funding (323)
Gene editing (54)
Generative AI (4)
Gene therapy (208)
GLP-1 (221)
Government (777)
Grass and pollen (2)
Guidances (161)
Healthcare (5016)
HIV (9)
Huntington's disease (10)
IgA nephropathy (26)
Immunology and inflammation (51)
Immuno-oncology (12)
Indications (43)
Infectious disease (647)
Inflammatory bowel disease (46)
Inflation Reduction Act (1)
Influenza (30)
Intellectual property (48)
Interviews (43)
IPO (3730)
IRA (10)
Job creations (419)
Job search strategy (190)
JPM (14)
Kidney cancer (1)
Labor market (29)
Layoffs (103)
Leadership (7)
Legal (1059)
Liver cancer (33)
Longevity (9)
Lung cancer (187)
Lymphoma (83)
Machine learning (13)
Management (5)
Manufacturing (211)
MASH (19)
Medical device (6259)
Medtech (6314)
Mergers & acquisitions (3751)
Metabolic disorders (288)
mRNA (44)
Multiple sclerosis (51)
Neurodegenerative disease (73)
Neuropsychiatric disorders (14)
Neuroscience (704)
Neurotech (1)
NextGen: Class of 2026 (1383)
Non-profit (713)
Now hiring (7)
Obesity (124)
Opinion (52)
Ovarian cancer (68)
Pain (119)
Pancreatic cancer (100)
Parkinson's disease (81)
Partnered (7)
Patents (103)
Patient recruitment (178)
Peanut (27)
People (7873)
Pharmaceutical (9)
Pharmacy benefit managers (4)
Phase 1 (4399)
Phase 2 (6429)
Phase 3 (4661)
Pipeline (2367)
Policy (55)
Postmarket research (379)
Preclinical (1923)
Press Release (10)
Prostate cancer (68)
Psychedelics (4)
Radiopharmaceuticals (48)
Rare diseases (210)
Real estate (748)
Recruiting (7)
Regulatory (5132)
Reports (11)
Research institute (493)
Resumes & cover letters (39)
Rett syndrome (9)
RNA editing (8)
RSV (11)
Schizophrenia (18)
Series A (50)
Series B (32)
Service/supplier (1)
Sickle cell disease (20)
Special edition (5)
Spinal muscular atrophy (26)
Sponsored (11)
Startups (599)
Stomach cancer (1)
Supply chain (33)
Tariffs (11)
The Weekly (7)
Vaccines (218)
Venture capital (23)
Weight loss (90)
Women's health (38)
Worklife (4)
Date
Today (1)
Last 7 days (221)
Last 30 days (889)
Last 365 days (7122)
2026 (2975)
2025 (7134)
2024 (8059)
2023 (9854)
2022 (14029)
2021 (14104)
2020 (13173)
2019 (9966)
2018 (7394)
2017 (7144)
2016 (6573)
2015 (8048)
2014 (5906)
2013 (4863)
2012 (5226)
2011 (5272)
2010 (4590)
Location
Africa (98)
Alabama (36)
Alaska (3)
Arizona (64)
Arkansas (4)
Asia (8116)
Australia (1464)
California (2647)
Canada (751)
China (234)
Colorado (189)
Connecticut (115)
Delaware (95)
Europe (19728)
Florida (568)
Georgia (200)
Idaho (15)
Illinois (256)
India (22)
Indiana (201)
Iowa (2)
Japan (147)
Kansas (17)
Kentucky (6)
Louisiana (9)
Maine (27)
Maryland (343)
Massachusetts (1823)
Michigan (107)
Minnesota (321)
Mississippi (4)
Missouri (71)
Montana (12)
Nebraska (7)
Nevada (30)
New Hampshire (20)
New Jersey (858)
New Mexico (6)
New York (744)
North Carolina (487)
North Dakota (2)
Northern California (1312)
Ohio (126)
Oklahoma (5)
Oregon (11)
Pennsylvania (750)
Puerto Rico (5)
Rhode Island (13)
South America (140)
South Carolina (14)
Southern California (1121)
Tennessee (97)
Texas (465)
United States (10725)
Utah (132)
Virginia (71)
Washington D.C. (6)
Washington State (159)
West Virginia (3)
Wisconsin (13)
152,605 Results for "via surgical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
April 24, 2026
·
11 min read
GLP-1s
Novo Nordisk Agrees To Sell GLP-1 Drugs Via Hims & Hers, Ending Dispute
The companies have been embroiled in a row about compounded GLP-1 drugs that escalated to a lawsuit last month. The legal action has now been dropped and the former adversaries have struck a deal that could increase access to Novo’s obesity medicines.
March 9, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting
April 14, 2026
·
10 min read
Press Releases
RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum
April 8, 2026
·
9 min read
Press Releases
Vivex Announces New Peer-Reviewed Publication Demonstrating Long-Term Fusion Outcomes with VIA Form+™ in Lumbar Interbody Fusion
February 12, 2026
·
3 min read
Press Releases
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
March 27, 2026
·
11 min read
Press Releases
Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET
March 23, 2026
·
4 min read
Press Releases
Vicarious Surgical Reports First Quarter 2026 Financial Results
April 30, 2026
·
7 min read
Press Releases
Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer
May 12, 2026
·
7 min read
Press Releases
Medtronic announces CE Mark for Stealth AXiS™ surgical system
April 28, 2026
·
4 min read
1 of 15,261
Next
